Improving trends in glucocorticoid-induced osteoporosis management: 2002 to 2006

Clinical and Experimental Rheumatology

Volumn 25, Issue 5, 2007, Pages 728-733

  Mohammad, Ausaf ^a   Ryan, John G ^a   Ralph, Nicola ^a   Ryan, Caitriona ^a   O'Connell, Paul G ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Audit; Glucocorticoid; Glucocorticoid induced osteoporosis; Quality of care; Treatment

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; GLUCOCORTICOID; PARATHYROID HORMONE[1-34]; PREDNISOLONE; RALOXIFENE; VITAMIN D;

ADULT; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; CORTICOSTEROID INDUCED OSTEOPOROSIS; DATA EXTRACTION; DEMOGRAPHY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL RECORD REVIEW; OUTPATIENT CARE; PATIENT IDENTIFICATION; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TEACHING HOSPITAL; UNIVERSITY HOSPITAL;

ABSORPTIOMETRY, PHOTON; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CLINICAL AUDIT; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; QUALITY ASSURANCE, HEALTH CARE; RETROSPECTIVE STUDIES; RHEUMATIC DISEASES; RISK FACTORS;

EID: 37349110030     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. VAN STAA, TP, LEUFKENS, HG, COOPER, C: The Epidemiology of Corticosteroid-Induced Osteoporosis: A mtea-analysis. Osteoporosis Int 2002; 13: 777.
2. WOLINSKY FD, FITZGERALD JF, STUMP TE: The Effect of hip fracture on mortality, hospitalization, and functional status: A prospective study. Am J Public Health 1997; 87: 398.
3. CURTIS PH JR, CLARK WS, HERNDON CH: Vertebral fractures resulting from prolonged cortisone and corticotropin therapy. J Am Med Assoc 1954; 156: 467.
4. WEINSTEIN RS, NICHOLAS RW, MANOLAGAS SC: Apoptosis of osteocytes in glucocorticoid-induced osteoporosis of the hip. J Clin Endocrinol Metab 2000; 85: 2907-12.
5. TAKUMA A, KANEDA T, SATO T, NINOMIYA S, KUMEGAWA M, HAKEDA Y: Dexamethasone enhances osteoclast formation synergistically with transforming growth factor-β by stimulating the priming of osteoclast progenitors for differentiation into osteoclasts. J Biol Chem 2003; 278: 44667-74.
6. EASTELL R: Management of corticosteroid-induced osteoporosis. UK Consensus Group meeting on Osteoporosis. J Intern Med 1995; 237: 439-47.
7. DEVOGELAER JP, GOEMAERE S, BOONEN S et al.: Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: A consensus document of the Belgian Bone Club. Osteoporos Int 2006; 17: 8-19.
8. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. Arthritis Rheum 2001; 44: 1496-503.
9. GUZMAN-CLARK JR, FANG MA, SEHL ME, TRAYLOR L, HAHN TJ: Barriers in the management of glucocorticoid-induced osteoporosis. Arthritis Rheum 2007; 57: 140-6.
10. BELL R, CARR A, THOMPSON P: Managing corticosteroid-induced osteoporosis in medical outpatients. J R Coll Physicians Lond 1997; 31: 158-61.
11. PEAT ID, HEALY S, REID DA, RALSTON SH: Steroid induced osteoporosis: an opportunity for prevention? Ann Rheum Dis 1995; 54: 66-8.
12. WALSH LJ, WONG CA, PRINGLE M, TATTERSFIELD AE: Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: A cross-sectional study. BMJ 1996; 313: 344-6.
13. VAN STAA TP, LEUFKENS GH, ABENHAIM L, BEGAUD B, ZHANG B, COOPER C: Use of oral corticosteroids in the United Kingdom. QJM 2000; 93: 105-11.
14. BUCKLEY LM, MARQUEZ M, HUDSON J et al.: Variations in physicians'judgments about corticosteroid-induced osteoporosis by physician specialty. J Rheumatol 1998; 25: 2195-202.
15. SOLOMON DH, MORRIS C, CHENG H et al.: Medication use patterns for osteoporosis: An assessment of guidelines, treatment rates, and quality improvement interventions. Mayo Clin Proc 2005; 80: 194-202.
16. RYAN JG, O'CONNELL PG: Current management of corticosteroid-induced osteoporosis: Variations in awareness and management. Ir J Med Sci 2004; 173: 20-2.
17. BELCHETZ PE: Hormonal treatment of post-menopausal women [scee commentsc]. N Engl J Med 1994; 330: 1062.
18. DYTHAM C: Choosing and Using Statistics: A Biologist's Guide, 2nd ed., Blackwell Publishing Company, 2003.
19. SAMBROOK PN, EISMAN JA, CHAMPION D et al.: Determinants of axial bone loss in rheumatoid arthritis. Arthritis Rheum 1987; 30: 721-8.
20. ACR recommendations target prevention and treatment of glucocorticoid-induced osteoporosis. Task Force on Osteoporosis, American College of Rheumatology. Am Fam Physician 1997; 55: 1450-53.
21. REID DM: Editorial. Corticosteroid-induced osteoporosis: Guidelines for prevention - Are they useful? Br J Rheumatol 1997; 36; 1035-37.
22. SAAG KG, GEHLBACH SH, CURTIS JR, YOUKET TE, WORLEY K, LANGE JL: Trend in prevention of glucocorticoid-induced osteoporosis. J Rheumatol 2006; 33: 1651-7.
23. MORRIS CA, CABRAL D, CHENG H et al.: Patterns of bone mineral density testing: Current guidelines, testing rates, and interventions. J Gen Intern Med 2004; 19: 783-90.